Article

Is earlier always better? Timing of antifibrotic therapy and overall survival in idiopathic pulmonary fibrosis: a multicenter retrospective study

2026-04-26

Abstract excerpt

<title>Abstract</title> <p>Background Antifibrotic therapies slow functional decline and improve survival in patients with idiopathic pulmonary fibrosis (IPF). Although early initiation is generally recommended, the optimal timing of treatment in real-world clinical practice remains uncertain. In particular, the relationship between the interval from diagnosis to treatment initiation and overall survival (OS), a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d1552d69-72f6-5209-8fa1-79d8373a5bcf
DOI: 10.21203/rs.3.rs-9355521/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest

Is earlier always better? Timing of antifibrotic therapy and overall survival in idiopathic pulmonary fibrosis: a multicenter retrospective studyDOI 10.21203/rs.3.rs-9355521/v1Read

Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.Semantic proximity Read

Treatment patterns and patient journey in progressive pulmonary fibrosis: a cross-sectional surveySemantic proximity Read

Liver disease progression in patients with alpha-1 antitrypsin deficiency and protease inhibitor ZZ genotype with or without lung disease.Semantic proximity Read

Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort studySemantic proximity Read

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal Cancer.Semantic proximity Read

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort studySemantic proximity Read

TAPO in first-line osimertinib therapy and continuation of osimertinib.Semantic proximity Read

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Semantic proximity Read

Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.Semantic proximity Read

Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.Semantic proximity Read

A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung DiseaseSemantic proximity Read